Nutex Health reports Q4 results; authorizes stock repurchase program of up to $25M
Source: SeekingAlpha
2026-03-05 23:49:51 ET
More on Nutex Health
- Nutex Health: The $387 Million Receivables Problem And The Legislative Silver Bullet
- Nutex: Stellar Growth But Sustainability Doubts Linger
- Seeking Alpha’s Quant Rating on Nutex Health
- Historical earnings data for Nutex Health
- Financial information for Nutex Health
Read the full article on Seeking Alpha
For further details see:
Nutex Health reports Q4 results; authorizes stock repurchase program of up to $25M
Nutex Health Inc.
NASDAQ: NUTX
NUTX Trading
4.57% G/L:
$94.7825 Last:
129,504 Volume:
$89.90 Open:
NUTX Latest News
March 05, 2026 06:33:00 pm
NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM
February 25, 2026 05:29:00 pm
Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call
NUTX Stock Data
$716,950,844
4,460,965
0.08%
42
N/A
Healthcare Providers & Services
Healthcare
US
Houston
